Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of riluzole in preventing oxaliplatin-induced peripheral neuropathy in stage II/III colorectal cancer
2017-002320-25Phase 2Completed
- Sponsor
- Unicancer
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of riluzole in colorectal cancer (CRC) (2 arms), sponsored by Unicancer. Primary endpoint: Primary sensory neuropathy severity. Started Jun 2018; status: completed.
02
Drugs
riluzole
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2017-002320-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002320-25.